Mucins in ovarian cancer diagnosis and therapy
<p>Abstract</p> <p>Ovarian cancer is the most lethal gynecologic malignancy and the five-year survival rate is only 35% after diagnosis. Epithelial ovarian cancer is a highly metastatic disease characterized by widespread peritoneal dissemination and ascites. The death incidences f...
Main Authors: | Chauhan Subhash C, Kumar Deepak, Jaggi Meena |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-12-01
|
Series: | Journal of Ovarian Research |
Online Access: | http://www.ovarianresearch.com/content/2/1/21 |
Similar Items
-
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
by: Zaman Mohd Saif, et al.
Published: (2012-12-01) -
Scope of nanotechnology in ovarian cancer therapeutics
by: Yallapu Murali M, et al.
Published: (2010-08-01) -
Chapter Demographic and Clinical Characteristics of Mucinous Epithelial Ovarian Cancer, and Survival Following a Mucinous Epithelial Ovarian Cancer Diagnosis
Published: (2013) -
Chapter Demographic and Clinical Characteristics of Mucinous Epithelial Ovarian Cancer, and Survival Following a Mucinous Epithelial Ovarian Cancer Diagnosis
by: O'Malley, Cynthia D.
Published: (2013) -
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
by: Yallapu Murali M, et al.
Published: (2010-04-01)